Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00509275 | A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP) | PHASE1 | COMPLETED | 120 | — | — | Jul 1, 2007 | Aug 1, 2008 | May 30, 2017 | 9 | United States, Australia |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | W0027 |
| 2 | EXPERIMENTAL | W0027 |
| 3 | EXPERIMENTAL | W0027 |
| 4 | PLACEBO_COMPARATOR | Placebo |
| Name | Type | Description |
|---|---|---|
| W0027 | DRUG | capsule |
| Placebo | DRUG | Placebo |
Inclusion Criteria: * Subjects aged 18-65 years, who have been diagnosed with moccasin type tinea pedis (by positive dermatophyte culture, positive potassium hydroxide/calcofluor white preparation, and a Total Signs and Symptoms Score of at least 4). * Females of childbearing potential must use con...